ChiCTR-IOR-15007421
尚未开始
/
/
/
2015-11-18
/
/
lacerated wound
以 "外科癒合劑" 或 "縫針" 方法處理傷口之成效研究計劃
以 "外科癒合劑" 或 "縫針" 方法處理傷口之成效研究計劃
以 "外科癒合劑" 或 "縫針" 方法處理傷口之成效
随机平行对照
其它
Parallel 1:1 ratio by using computer generated method with block size four.
/
Nethersole school of Nursing
/
0;15
/
1990-01-01
1990-01-01
/
The inclusion criteria are listed as follows: (a) Chinese pediatric patients, 7 years to 17 years; (b) with sustained laceration wound of <5 cm in length but without deep structure injury (bone and joint involvement or neurovascular damage to the tissue being repaired); and 3) availability of parent consent.；
登录查看The exclusion criteria are listed as follows: (a) underlying structural injury (e.g., muscle, tendon, bone, joint, or neuro-muscular injury, and scalp wounds); (b) complicated wound (severely crushed injury or stellate lacerations in areas with dense natural hair or under prolonged moisture or friction); (c) injury in mucosal surfaces, across muco-cutaneous junctions (e.g., oral cavity and lips), or skin, which may be regularly exposed to bodily fluids; d) high risk of infection (heavily contaminated, actively infected wounds, animal bites, or wounds sustained for more than 12 hours, and wound requiring debridement to remove nonviable tissue); e) high tension (e.g., chin) or deep wound that required deep sutures (e.g., torso or joint); f) eyelid or peri-orbital laceration; g) known hypersensitivity to tissue adhesive; and h) psychiatric cognitive disorder indicated in medical record (such as autism and mental retardation); h) wound that have potentially important consequences as perceived by parents.；
登录查看Eliza Wong
/
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24
Insight数据库2024-10-24
Being科学2024-10-24
医药观澜2024-10-24
甘李药业2024-10-24
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
